losartan
losartan is a pharmaceutical drug with 180 clinical trials. Currently 18 active trials ongoing. Historical success rate of 83.1%.
Success Metrics
Based on 98 completed trials
Phase Distribution
Phase Distribution
30
Early Stage
44
Mid Stage
67
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
78.4%
98 of 125 finished
21.6%
27 ended early
18
trials recruiting
180
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes
Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer
Effect of Losartan in Cystic Fibrosis (CF)-NIH Grant #133240
FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer
The Effect of Losartan on Cephalexin
Clinical Trials (180)
Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes
Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer
Effect of Losartan in Cystic Fibrosis (CF)-NIH Grant #133240
FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer
The Effect of Losartan on Cephalexin
Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease
Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma
Losartan + Sunitinib in Treatment of Osteosarcoma
Study to Use Oral Losartan to Decrease the Risk of Postoperative Scarring Following (ACL) Reconstruction
Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19
Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer
Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma
A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)
Secondhand Tobacco Smoke and Cardiovascular Disease
ACES - ACE Inhibitors Combined With Exercise for Seniors With Hypertension
Bariatric Surgery and Pharmacokinetics of Losartan
Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
Prevention of Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients
Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer (SHAPER)
Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 180